Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.980
+0.030 (1.54%)
Apr 29, 2026, 2:28 PM EDT - Market open
Palisade Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 133.39 | 9.82 | 12.43 | 12.38 | 10.5 | Upgrade
|
| Cash & Short-Term Investments | 133.39 | 9.82 | 12.43 | 12.38 | 10.5 | Upgrade
|
| Cash Growth | 1258.16% | -21.00% | 0.40% | 17.99% | 1339.64% | Upgrade
|
| Other Receivables | 0.26 | 0.02 | 0.15 | 1.44 | 0.15 | Upgrade
|
| Receivables | 0.26 | 0.02 | 0.15 | 1.44 | 0.15 | Upgrade
|
| Prepaid Expenses | 0.57 | 0.57 | 0.64 | 0.8 | 0.86 | Upgrade
|
| Other Current Assets | - | 0.08 | 0.11 | 0.11 | - | Upgrade
|
| Total Current Assets | 134.22 | 10.49 | 13.33 | 14.73 | 11.51 | Upgrade
|
| Property, Plant & Equipment | - | 0.09 | 0.21 | 0.31 | 0.11 | Upgrade
|
| Other Long-Term Assets | 0.12 | 0.3 | 0.52 | 0.72 | 0.89 | Upgrade
|
| Total Assets | 134.34 | 10.88 | 14.05 | 15.76 | 12.51 | Upgrade
|
| Accounts Payable | 0.77 | 1.11 | 0.7 | 1.76 | 1.32 | Upgrade
|
| Accrued Expenses | 3.49 | 1.96 | 1.61 | 1.06 | 0.97 | Upgrade
|
| Current Portion of Long-Term Debt | 0.07 | 0.08 | 0.16 | 0.09 | 0.09 | Upgrade
|
| Current Portion of Leases | - | 0.09 | 0.12 | 0.11 | 0.11 | Upgrade
|
| Other Current Liabilities | 0.31 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 4.64 | 3.24 | 2.59 | 3.01 | 2.5 | Upgrade
|
| Long-Term Leases | - | - | 0.09 | 0.21 | - | Upgrade
|
| Other Long-Term Liabilities | 0.33 | 0.15 | 0.06 | 0.06 | 2.65 | Upgrade
|
| Total Liabilities | 4.96 | 3.39 | 2.74 | 3.28 | 5.15 | Upgrade
|
| Common Stock | 1.59 | 0.03 | 0.01 | 0.03 | 0 | Upgrade
|
| Additional Paid-In Capital | 280.51 | 143.41 | 132.81 | 121.64 | 102 | Upgrade
|
| Retained Earnings | -152.73 | -135.94 | -121.51 | -109.19 | -94.64 | Upgrade
|
| Total Common Equity | 129.38 | 7.49 | 11.31 | 12.48 | 7.36 | Upgrade
|
| Shareholders' Equity | 129.38 | 7.49 | 11.31 | 12.48 | 7.37 | Upgrade
|
| Total Liabilities & Equity | 134.34 | 10.88 | 14.05 | 15.76 | 12.51 | Upgrade
|
| Total Debt | 0.07 | 0.17 | 0.37 | 0.4 | 0.2 | Upgrade
|
| Net Cash (Debt) | 133.31 | 9.65 | 12.06 | 11.98 | 10.3 | Upgrade
|
| Net Cash Growth | 1281.21% | -19.99% | 0.70% | 16.35% | - | Upgrade
|
| Net Cash Per Share | 2.39 | 6.81 | 26.45 | 204.12 | 826.06 | Upgrade
|
| Filing Date Shares Outstanding | 165.88 | 4.4 | 0.85 | 0.3 | 0.02 | Upgrade
|
| Total Common Shares Outstanding | 159.44 | 2.77 | 0.62 | 0.2 | 0.02 | Upgrade
|
| Working Capital | 129.59 | 7.26 | 10.74 | 11.72 | 9.01 | Upgrade
|
| Book Value Per Share | 0.81 | 2.71 | 18.30 | 63.57 | 387.81 | Upgrade
|
| Tangible Book Value | 129.38 | 7.49 | 11.31 | 12.48 | 7.36 | Upgrade
|
| Tangible Book Value Per Share | 0.81 | 2.71 | 18.30 | 63.57 | 387.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.